Biogen and partner Eisai had been hoping for good news from the review of Aduhelm (aducanumab) by the Centre for Medicare and Medicaid Services (CMS), but the draft decision means broad coverage ...

At the moment, the coverage for $56,000-a-year Aduhelm (aducanumab) is currently determined at the local level by Medicare administrative contractors representing 12 jurisdictions across the US ...

In a rare – and possibly unique – turn of events, both pharmacy company Biogen and its shareholders have asked a federal ...

The federal government's Medicare program raised the premium it charges for its coverage partially because of an expected influx of Aduhelm claims. But doctors were hesitant to prescribe the ...

A person can refuse a Medicare annual wellness visit, although they are an opportunity to check for signs of health ...

Medicare Advantage plans that include Part D coverage also typically cover Xanax. Xanax is one of the most prescribed medications for mental health conditions in the United States, and many ...

Investors knocked Biogen stock down by more than 10% early Wednesday after the US Centers for Medicare and Medicaid Services set a limit on its coverage of Aduhelm, the company's drug to treat ...

Medicare Advantage may offer coverage, but this varies from plan to plan. You are not required to receive an annual wellness exam, and declining to schedule this visit will not affect your ...

Medicare provides coverage for certain types of medical transportation ... the ambulance company believes that Medicare will refuse to pay for the specific ambulance service The ambulance company ...

Whether you have a stand-alone drug plan or a Medicare Advantage plan that covers prescription medications, Part D drug coverage has four payment stages or phases. Here are two examples that ...

are covered by Medicare Part D or Medicare Advantage plans that include prescription drug coverage instead.) Mental health services like therapy or counseling, psychiatric evaluations, medication ...